Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Almer

Showing results (51-60 of 68) with videos related to

Pageof 7
Sort By:
Scandinavian Journal of Gastroenterology|May 30, 1998
Low symptomatic load in Crohn's disease with surgery and medicine as complementary treatmentsP Andersson, G Olaison, G Bodemar, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinoloneAngela M Nilius, Linus L Shen, Dena Hensey-Rudloff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Fluoroquinolone resistance in Streptococcus pyogenesSandra S Richter, Daniel J Diekema, Kris P Heilmann, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureusLaurel S Almer, Virginia D Shortridge, Angela M Nilius, et al.
Journal of Internal Medicine|August 19, 2007
Acute liver failure in Sweden: etiology and outcomeG Wei, A Bergquist, U Broomé, et al.
Gut|November 15, 2000
Genetic analyses of chromosome 12 loci in Crohn's diseaseS Lesage, H Zouali, J F Colombel, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2016
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patientsL Angelison, S Almer, A Eriksson, et al.
Pageof 7

Showing results (51-60 of 68) with videos related to

Sort By:
Pageof 7
Scandinavian Journal of Gastroenterology|May 30, 1998
Low symptomatic load in Crohn's disease with surgery and medicine as complementary treatmentsP Andersson, G Olaison, G Bodemar, et al.
Antimicrobial Agents and Chemotherapy|September 25, 2003
In vitro antibacterial potency and spectrum of ABT-492, a new fluoroquinoloneAngela M Nilius, Linus L Shen, Dena Hensey-Rudloff, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|January 23, 2003
Fluoroquinolone resistance in Streptococcus pyogenesSandra S Richter, Daniel J Diekema, Kris P Heilmann, et al.
Diagnostic Microbiology and Infectious Disease|July 11, 2002
Antimicrobial susceptibility and molecular characterization of community-acquired methicillin-resistant Staphylococcus aureusLaurel S Almer, Virginia D Shortridge, Angela M Nilius, et al.
Journal of Internal Medicine|August 19, 2007
Acute liver failure in Sweden: etiology and outcomeG Wei, A Bergquist, U Broomé, et al.
Gut|November 15, 2000
Genetic analyses of chromosome 12 loci in Crohn's diseaseS Lesage, H Zouali, J F Colombel, et al.
Inflammatory Bowel Diseases|July 21, 2010
RIP2 polymorphisms in inflammatory bowel diseasesR Thiébaut, V Douchin, C Jung, et al.
The American Journal of Gastroenterology|January 29, 2009
TNFSF15 polymorphisms are associated with susceptibility to inflammatory bowel disease in a new European cohortR Thiébaut, S Kotti, C Jung, et al.
Alimentary Pharmacology & Therapeutics|June 27, 2013
Infliximab as rescue therapy in hospitalised patients with steroid-refractory acute ulcerative colitis: a long-term follow-up of 211 Swedish patientsM Sjöberg, A Magnuson, J Björk, et al.
Alimentary Pharmacology & Therapeutics|December 28, 2016
Long-term outcome of infliximab treatment in chronic active ulcerative colitis: a Swedish multicentre study of 250 patientsL Angelison, S Almer, A Eriksson, et al.
Pageof 7